Health Care Supplies(IN00300.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Health Care Supplies
IN00300.US
News
View More

2 New IPO Stocks Hit the Market – Morgan Stanley Picks the Superior One to Buy

Morgan Stanley highlights two new IPOs, with Medline (MDLN) being a key focus. Medline, a major healthcare supplier, raised $6.26 billion in its IPO, making it the largest of 2025. Analyst Patrick Wood rates MDLN as Overweight (Buy) with a $48 price target, suggesting a 10% upside. The stock has a Strong Buy consensus rating, with shares currently priced at $43.41 and an average target of $47.24, indicating a potential 9% gain over the next year. The U.S. IPO market is recovering, with 342 companies going public in 2023, raising over $75 billion.

Tip Ranks·
US
MDLN
+1.31%
Tip Ranks·
US
MDLN
+1.31%

REG - Brown Advisory US - Portfolio Update

Brown Advisory US Smaller Companies PLC has released its month-end portfolio update as of December 31, 2025. The top holdings include CCC Intelligent Solutions Holdings Inc (3.67%), Waste Connections Inc (3.44%), and Establishment Labs Holdings Inc (3.28%), among others, totaling 29.49% of total assets. The sector breakdown shows Industrials at 34.30%, Information Technology at 21.20%, and Healthcare at 15.91%, with a total of 100%. For further inquiries, contact FundRock Partners Limited, Company Secretary.

London Stock Exchange·
US
WCN
+1.06%
US
ESTA
+1.63%
US
CCCS
0.00%
London Stock Exchange·
US
WCN
+1.06%
US
ESTA
+1.63%
US
CCCS
0.00%

ICU Medical Receives Health Canada Clearance for Plum Solo and Plum Duo IV Pumps

ICU Medical Inc. has received Health Canada clearance for its Plum Solo and Plum Duo IV pumps, which include LifeShield infusion safety software. This approval enables Canadian healthcare organizations to access this new precision infusion technology, enhancing ICU Medical’s IV Performance Platform in Canada. No other organizations were mentioned in the announcement.

Reuters·
US
ICUI
+0.16%
Reuters·
US
ICUI
+0.16%

Evercore ISI Sticks to Its Hold Rating for DENTSPLY SIRONA (XRAY)

Evercore ISI has maintained a Hold rating on DENTSPLY SIRONA (XRAY) with a price target of $12.00. Analyst Elizabeth Anderson CFA, who covers the Healthcare sector, has an average return of -1.1% and a 49.67% success rate on her recommendations. Additionally, DENTSPLY SIRONA received a Hold rating from TipRanks, while another report downgraded the stock to a Sell.

Tip Ranks·
US
XRAY
+1.81%
Tip Ranks·
US
XRAY
+1.81%

Dentsply Sirona Inc - Co And Patterson Dental Renew Distribution Agreement

DENTSPLY SIRONA Inc :DENTSPLY SIRONA INC - CO AND PATTERSON DENTAL RENEW DISTRIBUTION AGREEMENT

Reuters·
US
XRAY
+1.81%
Reuters·
US
XRAY
+1.81%
Posts
View More

Request for GPT-5 Pro Reasoned for 28m 27s Indeed, human affairs are the most complex. It took nearly half an hour to reach a conclusion: Below is a clear explanation of **"people" and "reputation/eva......

© 2026 Longbridge｜Disclaimer